ArticleDrug safety2022

A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS).

Lorenzo Villa-Zapata et al.PubMed ↗Publisher ↗

No numbers read from the abstract.